Seattle’s Life Sciences Market Holds Steady Despite Declines in Funding

Seattle’s life sciences market remains stable, supported by major leases and new lab space deliveries. Activity from companies like SystImmune and Seattle Children’s Research Institute highlights continued demand. While vacancy and funding dipped slightly, the region maintains strong fundamentals, a growing talent base, and a top 10 national ranking, reinforcing confidence in its long term outlook.